Healthpeak Q3 FFO Beats Estimates, Same-Store NOI Rises Y/Y

Core Insights - Healthpeak Properties, Inc. reported third-quarter 2025 adjusted funds from operations (FFO) per share of 46 cents, surpassing the Zacks Consensus Estimate of 45 cents and matching the prior year's figure [1][8] - The company generated revenues of $705.9 million, exceeding the Zacks Consensus Estimate of $696 million, with a slight year-over-year increase [2][8] - Total merger-combined same-store cash (adjusted) net operating income (NOI) grew by 0.9% year-over-year, with outpatient medical and CCRC segments showing growth of 2.0% and 9.4%, respectively, while the lab segment declined by 3.2% [3][8] Financial Performance - Healthpeak executed new and renewal leases totaling 339,000 square feet in the lab portfolio, achieving positive cash-releasing spreads of 4.6% on renewals, while the outpatient medical portfolio saw 1.2 million square feet with 5.4% cash-releasing spreads [4] - Interest expenses increased by 3.6% year-over-year to $76.8 million [4][8] - The company exited the quarter with cash and cash equivalents of $91 million, up from $89.4 million as of June 30, 2025, and had a net debt to adjusted EBITDAre ratio of 5.3X [5] 2025 Outlook - Healthpeak reaffirmed its guidance for 2025, expecting adjusted FFO per share to be between $1.81 and $1.87, with the Zacks Consensus Estimate at $1.83 [6] - The company anticipates total merger-combined same-store cash (adjusted) NOI growth in the range of 3-4% [6]